Eosinophilic Esophagitis and Celiac Disease: A true association or coincidence? von Watkins, Runa Diwadkar, Blanchard, Samra S

Volltext

Oral Vancomycin as an Adjuvant Treatment in IBD von Ayers, Travis D, Leonard-Puppa, Elaine, Kader, Howard A, Waddell, Jaylyn, Watkins, Runa D, Blanchard, Samra S, Safta, Anca M, Rawal, Nidhi

Volltext

Eosinophilic Esophagitis and Celiac Disease von Watkins, Runa D., Blanchard, Samra S.

Volltext

Myelolipoma After Infliximab Treatment for Crohn's Disease von Cesa, Kevin, Puppa, Elaine Leonard, Eslami, Katayoun, Blanchard, Samra M., Watkins, Runa D.

Volltext

Myelolipoma After Infliximab Treatment for Crohn's Disease von Cesa, Kevin, Puppa, Elaine Leonard, Eslami, Katayoun, Blanchard, Samra M, Watkins, Runa D

Volltext

Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID von Weaver, Kimberly N, Zhang, Xian, Dai, Xiangfeng, Watkins, Runa, Adler, Jeremy, Dubinsky, Marla C, Kastl, Arthur, Bousvaros, Athos, Strople, Jennifer A, Cross, Raymond K, Higgins, Peter D R, Ungaro, Ryan C, Bewtra, Meenakshi, Bellaguarda, Emanuelle, Farraye, Francis A, Boccieri, Margie E, Firestine, Ann, Kappelman, Michael D, Long, Millie D

Volltext

Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease von Brenner, Erica J., Weaver, Kimberly N., Zhang, Xian, Kastl, Arthur J., Strople, Jennifer A., Adler, Jeremy, Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K., Higgins, Peter D.R., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Chun, Kelly Y., Zikry, Michael, Bastidas, Monique, Firestine, Ann, Craig, Riley G., Boccieri, Margie E., Long, Millie D., Kappelman, Michael D.

Volltext

Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease von Kastl, Arthur J, Brenner, Erica J, Weaver, Kimberly N, Zhang, Xian, Strople, Jennifer A, Adler, Jeremy, Dubinsky, Marla C, Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K, Higgins, Peter D R, Ungaro, Ryan C, Bewtra, Meenakshi, Bellaguarda, Emanuelle A, Farraye, Francis A, Chun, Kelly Y, Zikry, Michael, Bastidas, Monique, Firestine, Ann M, Craig, Riley G, Boccieri, Margie E, Long, Millie D, Kappelman, Michael D

Volltext

Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease von Kastl, Arthur J., Weaver, Kimberly N., Zhang, Xian, Strople, Jennifer A., Adler, Jeremy, Kelsen, Judith R., Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Colin, Cross, Raymond K., Higgins, Peter D. R., Ungaro, Ryan, Bewtra, Meenakshi, Bellaguarda, Emanuelle A., Farraye, Francis A., Chun, Kelly, Zikry, Michael, Bastidas, Monique, Boccieri, Margie E., Firestine, Ann, Long, Millie D., Kappelman, Michael D.

Volltext

Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease von Weaver, Kimberly N, Zhang, Xian, Dai, Xiangfeng, Chen, Wenli, Watkins, Runa, Adler, Jeremy, Dubinsky, Marla C, Kastl, Arthur, Bousvaros, Athos, Strople, Jennifer A, Cross, Raymond K, Higgins, Peter D R, Ungaro, Ryan C, Bewtra, Meenakshi, Bellaguarda, Emanuelle, Farraye, Francis A, Craig, Riley, Hernandez, Cristian, Boccieri, Margie E, Firestine, Ann, Chun, Kelly Y, Long, Millie D, Kappelman, Michael D

Volltext

Tu1843 LONG-TERM EFFECTIVENESS AND DURABILITY OF SARS-COV-2 VACCINATION AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE von Brenner, Erica J., Weaver, Kimberly, Zhang, Xian, Kastl, Arthur, Strople, Jennifer A., Adler, Jeremy, Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K., Higgins, Peter D., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle, Farraye, Francis A., Chun, Kelly Y., Zikry, Michael, Bastidas, Monique, Firestine, Ann M., Craig, Riley, Boccieri, Margie, Long, Millie D., Kappelman, Michael

Volltext

Tu1844 MAGNITUDE OF SARS-COV-2 SPIKE ANTIBODY LEVEL FOLLOWING VACCINATION IS NOT ASSOCIATED WITH RISK OF DEVELOPING SYMPTOMATIC COVID-19 AMONG PATIENTS WITH INFLAMMATORY BOWEL DISE... von Brenner, Erica J., Weaver, Kimberly, Zhang, Xian, Kastl, Arthur, Strople, Jennifer A., Adler, Jeremy, Dubinsky, Marla C., Bousvaros, Athos, Watkins, Runa, Dai, Xiangfeng, Chen, Wenli, Cross, Raymond K., Higgins, Peter D., Ungaro, Ryan C., Bewtra, Meenakshi, Bellaguarda, Emanuelle, Farraye, Francis A., Chun, Kelly Y., Zikry, Michael, Bastidas, Monique, Firestine, Ann M., Craig, Riley, Boccieri, Margie, Long, Millie D., Kappelman, Michael

Volltext

Su1492: STRONG HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE ADDITIONAL DOSE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASES von Kappelman, Michael, Weaver, Kimberly N., Zhang, Xian, Chun, Kelly Y., Watkins, Runa, Adler, Jeremy, Dubinsky, Marla, Kastl, Art, Bousvaros, Athos, Cross, Raymond K., Higgins, Peter D., Ungaro, Ryan C., Bewtra, Meenakshi, Strople, Jennifer A., Bellaguarda, Emanuelle, Farraye, Francis A., Dai, Xiangfeng, Boccieri, Margie, Firestine, Ann, Fernando, Manory, Bastidas, Monique, Zikry, Michael, Long, Millie D.

Volltext